1-1 of 1
Julian R Molina, MD PhD
Close
Sort by
Journal Articles

Risk Factors for Increased Length of Stay (LOS) in Patients with Hematological Malignancies Electively Admitted for Chemotherapy

Christopher E. Wee, MD, Jilan Kubusek, PharmD, Irbaz Riaz, MDMMSc, Robert Wolf, PharmD, RPh, Julian R Molina, MD PhD, Naseema Gangat, MBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 2138.
https://doi.org/10.1182/blood-2019-127367
Published: 2019